The association of homocysteine and its determinants MTHFR genotype, folate, vitamin B12 and vitamin B6 with bone mineral density in postmenopausal British women

Bone

Volumn 40, Issue 3, 2007, Pages 730-736

  Baines, M ^a   Kredan, M B ^a   Usher, J ^a   Davison, A ^a   Higgins, G ^a   Taylor, W ^a   West, C ^a   Fraser, W D ^a   Ranganath, L R ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Bone mineral density; Folate; Homocysteine; MTHFR genotype; Smoking

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD LEVEL; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; CALCANEUS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION COEFFICIENT; CREATININE BLOOD LEVEL; FEMALE; FOLIC ACID BLOOD LEVEL; FRACTURE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; INCIDENCE; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; SMOKING; STATISTICAL ANALYSIS; VITAMIN BLOOD LEVEL; WEIGHT REDUCTION;

AGED; ALCOHOL DRINKING; BONE DENSITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OSTEOPOROSIS, POSTMENOPAUSAL; POLYMORPHISM, GENETIC; POSTMENOPAUSE; SMOKING; VITAMIN B 12; VITAMIN B 6;

EID: 33846593344     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.10.008     Document Type: Article

References (33)

1. Schimke R.N., McKusick V.A., Huang T., and Pollock A.D. Homocystinuria. Studies of 20 families with 38 affected members. JAMA 193 (1965) 87-95
2. van Meurs J.B.J., Dhonukshe-Rutten R.A.M., Pluijm S.M.F., van der Klift M., de Jonge R., et al. Homocysteine levels and the risk of osteoporotic fracture. N. Engl. J. Med. 350 (2004) 2033-2041
3. McLean R.R., Jacques P.F., Selhub J., Tucker K.L., Samelson E.J., et al. Homocysteine as a predictive factor for hip fracture in older persons. N. Engl. J. Med. 350 (2004) 2042-2049
4. Miyao M., Morita H., Hosai T., Kurihara H., Inoue S., et al. Association of methylenetetrehydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif. Tissue Int. 66 (2000) 190-194
5. Abrahamsen B., Madsen J.S., Tofteng C.L., Stilgren L., and Bladjberg E.M. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish Osteoporosis Prevention Study. J. Bone Miner. Res. 18 (2003) 723-729
6. Jorgenssn H.L., Madsen J.S., Madsen B., Saleh M.M., Abrahamsen B., Fenger M., et al. Association of a common allelic polymorphism (C677T) in the methylenetetrahydrofolate reductase gene with a reduced risk of osteoporotic fractures. A case control study in Danish postmenopausal women. Calcif. Tissue Int. 71 (2002) 386-392
7. 12 to bone mineral density of postmenopausal women. Bone 33 (2003) 956-959
8. Barr R.J., Adebajo A., Fraser W.D., Halsey J.P., Kelsey C., Stewart A., et al. Can peripheral DXA measurements be used to predict fractures in elderly women living in the community?. Osteoporos. Int. 16 (2005) 1177-1183
9. Zhang M., Gunter E.W., and Pfeiffer C.M. Evaluation of the Drew Scientific DS30 homocysteine assay in comparison with the Centers for Disease Control and Prevention Reference HPLC method. Clin. Chem. 47 (2001) 966-967
10. Golbahar J., Hamidi A., Aminzadeh M.A., and Omrani G.R. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C677T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study. Bone 35 (2004) 760-765
11. von Ahsen N., Oellerisch M., and Schutz E. A method for homogenous color-compensated genotyping of Factor V (G1691A) and methylenetetrahydrofolate reductase (C677T) mutations using real-time multiplex fluorescence PCR. Clin. Biochem. 33 (2000) 535-539
12. Mudd S.H., Skovby F., Levy H.L., Pettigrew K.D., Wilcken B., et al. The natural history of homocystinuria due to cystathione beta-synthase deficiency. Am. J. Hum. Genet. 37 (1984) 1-31
13. Lim M., Lau E.M.C., and Woo J. Methylenetetrahydrofolate reductase polymorphism (MTHFR C677T) and bone mineral density in Chinese men and women. Bone 35 (2004) 1369-1374
14. Villadsen M.M., Bunger M.H., Carstens M., Stenkjaer L., and Langdahl B.L. Methyleneterrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD. Osteoporos. Int. 16 (2005) 411-416
15. McLean R.R., Karasik D., Selhub J., Tucker K.L., Ordovas J.M., et al. Association of a common polymorphism in the Methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate status. J. Bone Miner. Res. 19 (2004) 410-418
16. Fraser W.D. The burden of osteoporosis and the case for disease management. Dis. Manag. Health Outcomes 12 (2004) 409-418
17. Morris M.S., Jacques P.F., and Selhub J. Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone 37 (2005) 234-242
18. Macdonald H.M., McGuigan F.E., Fraser W.D., New S.A., Ralston S.H., and Reid D.M. Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density. Bone 35 (2004) 957-964
19. 12 is associated with lower BMD: The Framingham Osteoporosis Study. J. Bone Miner. Res. 20 (2005) 152-158
20. Dhonukshe-Rutten R.A.M., Lips M., de Jong N., Chin A., Paw M.J.M., Hiddink G.J., et al. Vitamin B-12 status is associated with bone mineral content and bone mineral density in frail elderly women but not in men. J. Nutr. 133 (2003) 801-807
21. Stone K.L., Bauer D.C., Sellmeyer D., and Cummings S.R. Low serum vitamin B-12 levels are associated with increased hip bone loss in older women: a prospective study. J. Clin. Endocrinol. Metab. 89 (2004) 1217-1221
22. Rapuri P.B., Gallagher J.C., Balhorn K.E., and Rayschon K.L. Smoking and bone metabolism in elderly women. Bone 27 (2000) 429-436
23. Pagan K., Hou J., Goldenberg R.L., Cliver S.P., and Tamura T. Effect of smoking on serum concentrations of total homocysteine and B vitamins in mid-pregnancy. Clin. Chim. Acta 306 (2001) 103-109
24. Sobszak A. The effects of tobacco smoke on the homocysteine level-A risk factor of atherosclerosis. Addict. Biol. 8 (2003) 147-158
25. Sobszak A., Wardas W., Zielinska-Danch W., and Pawlicki K. The influence of smoking on plasma homocysteine and cysteine levels in passive and active smokers. Clin. Chem. Lab. Med. 42 (2004) 408-414
26. Gabriel H.E., Crott J.W., Ghandour H., Dallal G.E., Choi S.-.W., Keyes M.K., et al. Chronic cigarette smoking is associated with diminished folate status, altered folate form distribution, and increased genetic damage in the buccal mucosa of healthy adults. Am. J. Clin. Nutr. 83 (2006) 835-841
27. Abrahamsen B., Madsen J.S., Tofteng C.L., Stilgren L., Bladbjerg E.M., et al. Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake ? Analysis of food records from the Danish osteoporosis prevention study. Bone 36 (2005) 577-583
28. Hermann M., Widmann T., and Hermann W. Homocysteine-A newly recognised risk factor for osteoporosis. Clin. Chem. Lab. Med. 43 (2005) 1111-1117
29. Lubec B., Fang-Kircher S., Lubec T., Blom H.J., and Boers G.H.J. Evidence for McKuisik's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim. Biophys. Acta 1315 (1996) 159-162
30. Chwatko G., and Jakubowski H. The determination of homocysteine-thiolactone in human plasma. Anal. Biochem. 337 (2005) 271-277
31. Liu G., Nellaiappan K., and Kagan H.M. Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria. J. Biol. Chem. 272 (1997) 32370-32377
32. Raposo B., Rodriguez C., Martinez-Gonzalez J., and Badimon L. High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells. Atherosclerosis 177 (2004) 1-8
33. Herrmann M., Widmann T., Colaianna G., Colucci S., Zallone A., and Herrman W. Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin. Chem. 51 (2005) 2348-2353